Gaurav S Gulsin, Georgios Tzimas, Kenneth-Royce Holmes, Hidenobu Takagi, Stephanie L Sellers, Philipp Blanke, Lynne M H Koweek, Bjarne L Nørgaard, Jesper Jensen, Mark G Rabbat, Gianluca Pontone, Timothy A Fairbairn, Kavitha M Chinnaiyan, Pamela S Douglas, Whitney Huey, Hitoshi Matsuo, Niels P R Sand, Koen Nieman, Jeroen J Bax, Tetsuya Amano, Tomohiro Kawasaki, Takashi Akasaka, Campbell Rogers, Daniel S Berman, Manesh R Patel, Bernard De Bruyne, Sarah Mullen, Jonathon A Leipsic
Impact of Coronary CT Angiography-derived Fractional Flow Reserve on Downstream Management and Clinical Outcomes in Individuals with and without Diabetes.
Purpose: To compare the clinical use of coronary CT angiography (CCTA)-derived fractional flow reserve (FFR) in individuals with and without diabetes mellitus (DM).
Materials and methods: This secondary analysis included participants (enrolled July 2015 to October 2017) from the prospective, multicenter, international The Assessing Diagnostic Value of Noninvasive CT-FFR in Coronary Care (ADVANCE) registry (ClinicalTrials.gov identifier, NCT02499679) who were evaluated for suspected coronary artery disease (CAD), with one or more coronary stenosis ≥30% on CCTA images, using CT-FFR. CCTA and CT-FFR findings, treatment strategies at 90 days, and clinical outcomes at 1-year follow-up were compared in participants with and without DM.
Results: The study included 4290 participants (mean age, 66 years ± 10 [SD]; 66% male participants; 22% participants with DM). Participants with DM had more obstructive CAD (one or more coronary stenosis ≥50%; 78.8% vs 70.6%, P < .001), multivessel CAD (three-vessel obstructive CAD; 18.9% vs 11.2%, P < .001), and proportionally more vessels with CT-FFR ≤ 0.8 (74.3% vs 64.6%, P < .001). Treatment reclassification by CT-FFR occurred in two-thirds of participants which was consistent regardless of the presence of DM. There was a similar graded increase in coronary revascularization with declining CT-FFR in both groups. At 1 year, presence of DM was associated with higher rates of major adverse cardiovascular events (hazard ratio, 2.2; 95% CI: 1.2, 4.1; P = .01). However, no between group differences were observed when stratified by stenosis severity (<50% or ≥50%) or CT-FFR positivity.